Cell Source Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
0.50
0.90
0.40
-
Gross Income
-
0.50
0.90
0.40
-
SG&A Expense
25.60
4,086.30
2,317.60
2,274.40
2,003.10
EBIT
25.60
4,086.70
2,318.50
2,274.80
2,003.10
Unusual Expense
-
2.70
208.30
135.20
294.20
Non Operating Income/Expense
-
32.00
2.00
56.40
70.10
Interest Expense
-
-
391.90
616.10
478.70
Pretax Income
25.60
4,057.50
2,504.10
3,082.50
2,117.40
Consolidated Net Income
25.60
4,057.50
2,504.10
3,082.50
2,117.40
Net Income
25.60
4,057.50
2,504.10
3,082.50
2,117.40
Net Income After Extraordinaries
25.60
4,057.50
2,504.10
3,082.50
2,117.40
Net Income Available to Common
25.60
4,057.50
2,504.10
3,323.10
2,568.70
EPS (Basic)
0.00
0.18
0.10
0.12
0.09
Basic Shares Outstanding
5,896.50
22,188.70
25,718.60
26,774.90
27,549.90
EPS (Diluted)
0.00
0.18
0.10
0.12
0.09
Diluted Shares Outstanding
5,896.50
22,188.70
25,718.60
26,774.90
27,549.90
EBITDA
25.60
4,086.30
2,317.60
2,274.40
2,003.10
Preferred Dividends
-
-
-
240.60
451.30
About Cell Source
View Profile
